Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMSO for prevention of capsular contracture in breast reconstruction
NCT02206477Phase 3Unknown
- Sponsor
- Rabin Medical Center
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Dimethyl sulfoxide in Breast capsular contracture, sponsored by Rabin Medical Center. Primary endpoint: Reduction of 50% or more in capsular contracture incidence at 3.5 years. Status: unknown.
02
Drugs
Dimethyl sulfoxide
03
Conditions
Breast capsular contracture
Beyond the preview
Go deeper on NCT02206477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206477.